These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14747261)

  • 1. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
    Arranz A; Andia V; López-Guzmán A
    Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Lipoblastoma-like" lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes?
    Jermendy G; Nádas J; Sápi Z
    Diabetologia; 2000 Jul; 43(7):955-6. PubMed ID: 10952472
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
    Griffin ME; Feder A; Tamborlane WV
    Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
    [No Abstract]   [Full Text] [Related]  

  • 6. Lispro insulin-induced lipoatrophy: a new case.
    Al-Khenaizan S; Al Thubaiti M; Al Alwan I
    Pediatr Diabetes; 2007 Dec; 8(6):393-6. PubMed ID: 18036067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
    Ampudia-Blasco FJ; Hasbum B; Carmena R
    Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
    [No Abstract]   [Full Text] [Related]  

  • 8. [Picture of the month: insulin-related lipoatrophy].
    Yazdanyar S; Dolmer B; Strauss G
    Ugeskr Laeger; 2011 Aug; 173(33):1968. PubMed ID: 21849139
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human insulin-induced lipoatrophy.
    Felner EI
    J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoatrophy is a thing of the past, or is it?
    Hussein SF; Siddique H; Coates P; Green J
    Diabet Med; 2007 Dec; 24(12):1470-2. PubMed ID: 17976201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mixing glargine and short-acting insulin analogs on glucose control.
    Kaplan W; Rodriguez LM; Smith OE; Haymond MW; Heptulla RA
    Diabetes Care; 2004 Nov; 27(11):2739-40. PubMed ID: 15505016
    [No Abstract]   [Full Text] [Related]  

  • 14. Glargine and lispro: two cases of mistaken identity.
    Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
    Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lipoatrophy after insulin injections can be treated with lipofilling].
    Lund PS; Sjøstrand H; Matzen SH
    Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A word of caution on the use of lispro.
    Bartsocas CS
    Diabetes Care; 1998 Mar; 21(3):462. PubMed ID: 9540035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].
    Dziura M; Wasikowa R
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):61-3. PubMed ID: 18577350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes.
    Hedman CA; Lindström T; Arnqvist HJ
    Diabetes Care; 2001 Jun; 24(6):1120-1. PubMed ID: 11375381
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.